Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 21
|
SFEBES2009
|
Next issue
Society for Endocrinology BES 2010
All volumes
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Programme
Volume Editors
Abstracts
Contents
Plenary Lecturers’ Biographical Notes
Society for Endocrinology Dale Medal Lecture
Common metabolic disease: lessons from the extremes
ea0021pl1
Society for Endocrinology Dale Medal Lecture
ea0021pl1biog
Society for Endocrinology Transatlantic Medal Lecture
Pathogenesis of pituitary adenomas
ea0021pl2
Society for Endocrinology Transatlantic Medal Lecture
ea0021pl2biog
Society for Endocrinology European Medal Lecture
Adrenal lumps and bumps: progress in the management of adrenal tumours
ea0021pl3
Society for Endocrinology European Medal Lecture
ea0021pl3biog
Society for Endocrinology Hoffenberg International Medal Lecture
Molecular and endocrine mechanism of seasonal reproduction in birds and mammals
ea0021pl4
Society for Endocrinology Hoffenberg International Medal Lecture
ea0021pl4biog
The British Thyroid Association Pitt Rivers Lecture
Thyroid associations
ea0021pl5
The British Thyroid Association Pitt-Rivers Lecture
ea0021pl5biog
Clinical Endocrinology Trust Visiting Professor Lecture
Endocrine hypertension: then and now
ea0021pl6
Clinical Endocrinology Trust Visiting Professor Lecture
ea0021pl6biog
Society for Endocrinology Medal Lecture
The hitchhiker's guide to the steroid galaxy
ea0021pl7
Society for Endocrinology Medal Lecture
ea0021pl7biog
Clinical Endocrinology Trust Lecture
Ubiquitination: the 'Kiss of Death' for human growth
ea0021pl8
Clinical Endocrinology Trust Lecture
ea0021pl8biog
Symposia
Novel mechanistic insights into thyroid diseases
Human mutations causing hypothyroidism
ea0021s1.1
Genetic mechanisms defining the response to thyroid hormone replacement
ea0021s1.2
The clinical spectrum of Pendred syndrome
ea0021s1.3
Novel mechanisms regulating the sodium iodide symporter: implications for thyroid tumourigenesis
ea0021s1.4
New endocrinology of bone
Insight into bone metabolism from human experiments of nature
ea0021s2.1
PPARG osteoporosis and diabetes mellitus
ea0021s2.2
Ghrelin and ghrelin signaling in bone metabolism
ea0021s2.3
FGF23, osteoblasts and phosphate homeostasis
ea0021s2.4
Stem cells - therapeutic potential and endocrine applications
Embryonic stem cells: derivation, propagation and therapeutic potential
ea0021s3.1
Pluripotent stem cells in the testis: restoring fertility
ea0021s3.2
Plasticity of pancreatic duct cells
ea0021s3.3
Reprogramming somatic cell identity: a source for replacement therapy
ea0021s3.4
Glucocorticoid action in inflammation: new insights into old mechanisms
Tissue-specific glucocorticoid action in inflammation and immunosuppression
ea0021s4.1
A novel mechanism of glucocorticoids to block autoimmunity
ea0021s4.2
Role of dual specificity phosphatases in biological responses to glucocorticoids
ea0021s4.3
Selective glucocorticid receptor agonists: control of inflammation without metabolic side effects?
ea0021s4.4
Vitamin D and calcium signalling in the immune system
Vitamin D and calcium signalling in autoimmune disease
ea0021s5.1
Anti-bacterial action of vitamin D
ea0021s5.2
Vitamin D as a risk factor for multiple sclerosis
ea0021s5.3
Vitamin D and regulatory T cells in allergy and asthma
ea0021s5.4
Fit or fat? Mechanisms regulating our metabolic fate
FTO variants are associated with overeating and many long-term health problems associated with obesity
ea0021s6.1
The phenotype of the FTO knockout mouse
ea0021s6.2
Gut-brain circuits controlling glucose homeostasis
ea0021s6.3
Mechanisms of serotonin regulating food intake: the role of the melanocortin pathway
ea0021s6.4
Dilemmas in managing gender identity problems in adolescence
Dilemmas in managing gender identity problems in adolescence: psychological issue
ea0021s7.1
Dilemmas in managing gender identity problems in adolescence: a medical overview
ea0021s7.2
Role of the circadian clock in endocrinology
Molecular basis of the circadian clock: regulation of endocrine rhythms
ea0021s8.1
Circadian clocks in adipose tissue
ea0021s8.2
The adrenal clock: impact on adrenal steroidogenesis
ea0021s8.3
Human clock genes and the metabolic syndrome
ea0021s8.4
Mechanisms and management of ovarian failure
Genetic mechanisms underlying ovarian insufficiency
ea0021s9.1
Mechanisms regulating ovarian reserve
ea0021s9.2
Can ovarian failure be predicted?
ea0021s9.3
Clinical management of ovarian insufficiency
ea0021s9.4
Clinical Management Workshops
Long-term consequences of endocrine diseases
Subclinical thyroid disease
ea0021cm1.1
Mild primary hyperparathyroidism
ea0021cm1.2
Long term consequences of Cushing's syndrome
ea0021cm1.3
Addisons disease
ea0021cm1.4
Endocrine incidentalomas: what to do with lumps and bumps
Thyroid
ea0021cm2.1
Pituitary incidentalomas
ea0021cm2.2
Adrenal lumps & bumps
ea0021cm2.3
Pancreas
ea0021cm2.4
Management of congenital adrenal hyperplasia across the lifespan
Prenatal diagnosis and treatment of CAH
ea0021cm3.1
Testicular adrenal rest tissue and male fertility in CAH
ea0021cm3.2
The adult with CAH: results of the UK congenital adrenal hyperplasia, adult study executive (CaHASE)
ea0021cm3.3
Quality of life in CAH: does it differ from adrenal insufficiency?
ea0021cm3.4
The management of thyroid cancer
Investigation of thyroid cancer from thyroid lump to surgical referral
ea0021cm4.1
Surgical treatment of thyroid cancer
ea0021cm4.2
Radioiodine treatment and long-term follow-up of differentiated thyroid cancer
ea0021cm4.3
Novel therapies for recurrent thyroid cancer
ea0021cm4.4
Nurse Session
Neuroendocrinology & case presentations
Abstract unavailable
ea0021n1.1
MEN-1 case presentation
ea0021n1.2
Abstract unavailable
ea0021n1.3
Has Carcincioid syndrome given me more than the average number of ears?
ea0021n1.4
Acromegaly – psychological aspects & case presentations
Abstract unavailable
ea0021n2.1
Abstract unavailable
ea0021n2.2
A psychological aspect of acromegaly
ea0021n2.3
McCune-Albright syndrome - case presentation
ea0021n2.4
Clinical Debate
(1)
This house believes that androgen replacement therapy should be offered to every hypogonadal woman
ea0021d1
This house believes that androgen replacement therapy, to get things going, should be offered to every hypogonadal woman
ea0021d2
Young Endocrinologists Session
Alternative careers for basic and clinical scientists
The 'darkside' - pharmaceutical industry for endocrinologists
ea0021ye1.1
Clinical biochemistry: one foot in the lab
ea0021ye1.2
Scientific communication - medical communication agencies
ea0021ye1.3
Government agencies - scientific roles in the civil service
ea0021ye1.4
Special Interest Group Sessions
Andrology Special Interest Group Session
Testosterone and mortality
ea0021sig1.1
Testosterone deficiency in metabolic syndrome
ea0021sig1.2
Late onset hypogonadism
ea0021sig1.3
Assay problems and treatment decisions: when and how to treat?
ea0021sig1.4
Pituitary Special Interest Group Session
'Growth hormone deficiency: a silent epidemic?'
ea0021sig2.1
Diagnostic difficulties of GH deficiency
ea0021sig2.2
GH: old hormone, new developments: therapeutic dilemmas
ea0021sig2.3
Future issues for GH replacement in adults
ea0021sig2.4
PCOS Special Interest Group Session
Androgen activation by 5[alpha]-reductase in patients with PCOS
ea0021sig3.1
Abstract unavailable
ea0021sig3.2
Abstract unavailable
ea0021sig3.3
Diagnosis and differential diagnosis of PCOS
ea0021sig3.4
Systems Biology Session
How to access funds and revolutionise your research
System biology: an overview (BBSRC strategy and funding streams)
ea0021sb1.1
Integration of live cell imaging and mathematical modelling: how to use systems biology to revolutionise your research
ea0021sb1.2
Mathematical modelling and endocrine research
ea0021sb1.3
Applications of systems biology for the endocrinologist
ea0021sb1.4
Systems biology: a funder's perspective
ea0021sb1.5
Senior Endocrinologists Session
(1)
Will we ever discover the mechanism of hormone action?
ea0021se1.1
Sleep, light and hormones in Antarctica
ea0021se1.2
Is the placenta just a parasitic endocrine organ?
ea0021se1.3
Are salivary hormone measurements a waste of time?
ea0021se1.4
La Mujer Barbuda by Ribera, 1631: a clinical conundrum
ea0021se1.5
Animated enchantment: an investigation of the enduring popularity of Walt Disney's first feature films
ea0021se1.6
Oral Communications
Diabetes and metabolism
IGF1 receptor and insulin receptor stoichiometry is a critical determinant of nitric oxide bioavailablity
ea0021oc1.1
Moderate maternal undernutrition results in epigenetic changes in the fetal hypothalamic feeding centres, but not in the fetal HPA axis
ea0021oc1.2
Adipose-specific knockout of androgen receptors in mice results in hyperinsulinaemia without obesity
ea0021oc1.3
The impact of saturated fatty acids and glucose on Toll-like receptor activated inflammatory pathways in human adipose tissue, in vitro
ea0021oc1.4
The immune-adrenal interface: effects of endotoxin on annexin 1 and formyl peptide receptor expression, cellular morphology and steroidogenesis in the mouse adrenal cortex
ea0021oc1.5
Testosterone improves glycaemic control, insulin resistance, body fat and sexual function in men with the metabolic syndrome and /or type 2 diabetes: a Multicentre European Clinical Trial: the TIMES2 Study
ea0021oc1.6
Prospective changes in glucocorticoid metabolism predict alterations in metabolic phenotype
ea0021oc1.7
Cortisol metabolism and hepatic expression of 11[beta]-hydroxysteroid dehydrogenase type 1 in patients with non-alcoholic fatty liver disease
ea0021oc1.8
Neuroendocrine tumours/pituitary
A novel mechanism of effect for somatostatin analogues: the role of AIP
ea0021oc2.1
Wnt/[beta]-catenin signalling is down-regulated in pituitary tumours from a multiple endocrine neoplasia type 1 (MEN1) mouse model
ea0021oc2.2
11C-Metomidate positron emission tomography (PET) scanning for Conn's syndrome
ea0021oc2.3
Geographical cluster of familial isolated pituitary adenoma kindreds with an identical AIP mutation
ea0021oc2.4
Differential effects of oestrogen on hypothalamic GnRH-I and GnRH-II gene expression in female rhesus macaques
ea0021oc2.5
Laying the foundation for neuroendocrine control of human reproduction: an investigation into the development of kisspeptin and neurokinin B networks
ea0021oc2.6
The spectrum of disease in diazoxide responsive hyperinsulinaemic hypoglycaemia
ea0021oc2.7
Diagnosis and localisation of insulinoma: the value of modern MRI in conjunction with calcium stimulation catheterisation
ea0021oc2.8
Young Endocrinologists prize session
In patients with primary hyperaldosteronism (PA), careful choice of patients for surgery using a combination of adrenal venous sampling (AVS) data and results of CT scanning, results in excellent post-operative blood pressure and serum potassium responses
ea0021oc3.1
[beta]-Cell specific overexpression of 11[beta]-hydroxysteroid dehydrogenase type 1 reverses high fat diet-induced [beta]-cell failure
ea0021oc3.2
Development of urinary steroid profiling as a high-throughput screening tool for the detection of malignancy in patients with adrenal tumours
ea0021oc3.3
MicroRNAs, let-7 and miR-302, have an altered expression in Men1-null embryos, consistent with abnormal embryonic development
ea0021oc3.4
A multisystem selenoprotein disorder with a thyroid signature
ea0021oc3.5
Men1 gene replacement therapy using a modified adenoviral vector demonstrates reduced proliferation rates in pituitary tumours from mice deleted for a multiple endocrine neoplasia type 1 allelle
ea0021oc3.6
Effects of glucocorticoids on Wnt gene expression in synovial fibroblasts: potential role in inflammatory bone loss
ea0021oc3.7
Identification and functional impact of novel mutations in the gene encoding 11[beta]-hydroxysteroid dehydrogenase type 1 in patients with hyperandrogenism
ea0021oc3.8
Bone and parathyroid
Multiple endocrine neoplasia type 1 (MEN-1) mutation analysis in patients with primary hyperparathyroidism under the age of 40 years
ea0021oc4.1
Intra-cellular availability of T3 in chondrocytes is essential for normal skeletal development and adult bone mass
ea0021oc4.2
Mice deleted for the transcription factor Gata3 have fewer parathyroid cells expressing Gcm2, develop hypocalcaemia and have an earlier onset of mortality when challenged with a low calcium-vitamin D diet
ea0021oc4.3
Rapid screening for novel bone phenotypes in 100 consecutive lines from the Wellcome Trust Sanger Institute Gene Targeting Programme
ea0021oc4.4
Dicer-dependant microRNAs regulate IGF-actions in the human placenta
ea0021oc4.5
Impaired osteoblast function in mice lacking the T3-responsive calcineurin inhibitor RCAN2
ea0021oc4.6
Persistent symptomatic improvement at more than 12 months after parathyroidectomy for primary hyperparathyrodism
ea0021oc4.7
Increased mortality in so-called 'mild' primary hyperparathyroidism: a population-based study
ea0021oc4.8
Steroids and thyroid
Familial GC resistance: a novel, naturally occurring mutation which has dominant negative effects on ligand-dependent and -independent GR action
ea0021oc5.1
De novo cortisol synthesis by primary human keratinocytes
ea0021oc5.2
Differential roles of PAPSS1 and PAPSS2 in the control of androgen synthesis
ea0021oc5.3
Induction of hypothyroidism with radioactive iodine therapy is associated with improved survival in patients with hyperthyroidism
ea0021oc5.4
Akt activation in a murine thyroid goitre model induced by the tumourigenic factor PBF
ea0021oc5.5
Is it safe for patients taking thyroxine to have a low but not suppressed serum TSH concentration?
ea0021oc5.6
X chromosome inactivation: the key to the female preponderance in Graves' disease?
ea0021oc5.7
The effect of genetic variation in PDE8B and DIO1 on thyroid hormone levels
ea0021oc5.8
Poster Presentations
Bone
Hypercalcaemia following a road traffic accident
ea0021p1
Protracted hungry bone syndrome post parathyroidectomy for primary hyperparathyroidism
ea0021p2
Hypertrophic pulmonary osteoarthropathy: not all longstanding raised bony alkaline phosphatase is Paget's disease
ea0021p3
Vitamin D sufficiency is rare in patients attending the Endocrine Antenatal Clinic even in the Caucasian population
ea0021p4
A mouse model, Slip, for an X-linked metaphyseal chondrodysplasia
ea0021p5
Bone mineral density in transitional endocrine clinic in a UK Teaching Hospital
ea0021p6
Osteoporosis in a young cohort: aetiology and gender differences in referral for DXA
ea0021p7
Vitamin D deficiency in primary hyperparathyroidism: prevalence and complications
ea0021p8
Osteoporosis in patients with chronic obstructive pulmonary disease
ea0021p9
Recurrence of spontaneously resolving hypercalcaemia, an unusual case
ea0021p10
Assessment of vitamin D status in patients with primary hyperparathyroidism
ea0021p11
Secondary preventative alendronate use in the prevention of fragility fractures in women above 75 years: the implementation of NICE guidance
ea0021p12
Is it time to replace the 24 h urine calcium: creatinine clearance ratio in the investigation of PTH-dependent hypercalcaemia?
ea0021p13
Mutational analysis of the PHEX gene in three patients with X-linked hypophosphatemic rickets: discovery of a novel point mutation
ea0021p14
A study on accuracy of Sestamibi and ultrasound scanning in identifying a solitary parathyroid adenoma in patients with primary hyperparathyroidism
ea0021p15
A novel GATA3 mutation, Tyr345Cys, in hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome results in abolished DNA binding
ea0021p16
Adenosine A2b receptors induce osteoblastogenesis whereas A1 receptors induce adipogenesis
ea0021p17
Management of primary hyperparathyroidism: are we following the guidelines?
ea0021p18
Hereditary renal calcification locus, Rcalc1, is associated with altered expression of cell survival genes
ea0021p19
Is Vitamin D deficiency a common cause of elevated PTH post-parathyroidectomy?
ea0021p20
Transient receptor potential cation channel, subfamily Vanilloid, member 5 (Trpv5) mutation (Ser682Pro) results in loss of apical membrane expression in the distal convoluted tubule, thereby resulting in hypercalciuria
ea0021p21
AMP-activated protein kinase (AMPK) regulates in vitro bone formation and bone mass in vivo
ea0021p22
A mouse model of early-onset renal failure, tertiary hyperparathyroidism and renal osteodystrophy
ea0021p23
The association among bone mineral density (BMD), 24-h mean sex hormone binding globulin (SHBG) concentration and its circadian rhythm
ea0021p24
Extra-pituitary expression of the prolactin gene in the bone and cartilage of an hPRL-Luc transgenic rat model
ea0021p25
Clinical practice/governance and case reports
Prevelance of various morbidity in North Indian adult obese patients
ea0021p26
Intervention to improve the management of diabetes in an academic primary care practice
ea0021p27
Are adrenal incidentalomas routinely referred to endocrinology services? An audit of referral pattern and appropriate investigation
ea0021p28
Kelp induced thyrotoxicosis
ea0021p29
Unusual presentation of a phaeochromocytoma
ea0021p30
Severe abdominal pain as presentation of Addison's disease in undiagnosed case of autoimmune polyglandular disease
ea0021p31
A case of polyglandular autoimmune syndrome type II and sarcoidosis
ea0021p32
The importance of HLA haplotype analysis in the polyglandular autoimmune syndromes
ea0021p33
Marked hypercalcaemia in a case of primary hyperparathyroidism
ea0021p34
'Mighty oaks from little acorns grow': a review of the development of Endocrine Nursing in the UK
ea0021p35
Altered time-effect profile of insulin glargine in overdose: a case report
ea0021p36
The pitfalls of abrupt reduction in glucocorticoid availability: illustrated in the treatment of Cushing's syndrome
ea0021p37
A case of microprolactinoma in a young man presenting as obesity despite regular heavy exercise
ea0021p38
Insulin induced hypoglycaemia in hospital inpatients
ea0021p39
Cushing's disease or pituitary incidentaloma?
ea0021p40
Extensive hirsutism, a valuable clue to a sinister pathology
ea0021p41
Aetiology of hyperprolactinaemia
ea0021p42
Testosterone replacement in the setting of Finasteride therapy: a therapeutic dilemma
ea0021p43
Addison's disease unmasking an occult systemic cause for cerebral ischaemic event
ea0021p44
Bariatric surgery in renal transplant recipients
ea0021p45
Intermittent galactorrhoea due to vacant episodes
ea0021p46
Assessment of risk factors given in GP referral letters for DEXA imaging
ea0021p47
Forensic endocrinology: a case report of factitious hypoglycaemia
ea0021p48
Severe hypoglycaemia leading to death in a patient with type 2 diabetes: insulinoma, sulphonylurea overdose or some other cause?
ea0021p49
Hypocalcaemia post total thyroidectomy: a clinical experience
ea0021p50
Mass in the median eminence: an unusual cause of confusion
ea0021p51
A case of fatal acute severe multi-factorial hyponatraemia
ea0021p52
An unusual presentation of polyendocrinopathy
ea0021p53
Acute fatty liver due to poor diabetic control
ea0021p54
A case of pseudo-carcinoid
ea0021p55
Investigating for Cushing's syndrome in a patient with increased BMI on rifampicin
ea0021p56
Granulomatous infiltration of the pituitary gland
ea0021p57
Audit on the safety of the insulin stress tests in a tertiary endocrine referral centre
ea0021p58
The use of insulin stress test as an assessment of tiredness
ea0021p59
A case of hypomagnesemia
ea0021p60
Hyperandrogenism with an abdominal mass but an ovarian source
ea0021p61
Diabetes insipidus secondary to caseating granulomatous disease
ea0021p62
Case of post menopausal steroid cell ovarian tumor
ea0021p63
A man with short stature and absent testis
ea0021p64
A rare case of isolated Cushing's disease from an ACTH and GH staining pituitary adenoma
ea0021p65
What a difference a dose makes! Unexpected test results lead to improved communication
ea0021p66
Hypercalcaemia due to PTH-related peptide secretion by small cell carcinoma of the ovary
ea0021p67
Low sodium and neurological findings: consider the diagnosis
ea0021p68
Androgen-producing tumour in a transposed ovary: a diagnostic difficulty
ea0021p69
Insulin autoimmune syndrome: a rare case of hypoglycaemia
ea0021p70
Improving patient awareness of antithyroid medications
ea0021p71
A case of hypogonadotrophic hypogonadism due a pituitary stalk tuberculoma
ea0021p72
Recurrent pituitary apoplexy
ea0021p73
A case of connective tissue disease complicated by multiple metabolic disorders
ea0021p74
The dangers of drinking liquorice tea
ea0021p75
A case of functional parathyroid adenoma
ea0021p76
A rare cause of a common problem
ea0021p77
Chronic lymphocytic infundibulitis with visual field defects, partial hypopituitarism and diabetes insipidus
ea0021p78
Misdiagnosed adrenal carcinoma with recurrence of Cushing's syndrome complicated by spontaneous hypoglycaemia
ea0021p79
Successful treatment of severe premenstrual dysphoria by a GnRH analogue and hormone add-back
ea0021p80
Hypertension in familial adenomatous polyposis (FAP): don't be conn'd!
ea0021p81
Pituitary apoplexy in Cushings disease
ea0021p81.1
Audit of hypothyroid management in pregnancy
ea0021p82
Severe hypomagnesaemia associated with proton pump inhibitor therapy
ea0021p83
Recurrent pregnancy-related hypokalaemia associated with Gitelman's syndrome
ea0021p84
An unusual cause of hyperparathyroidism
ea0021p85
Cushing's syndrome: a rare cause of hypertension in pregnancy
ea0021p86
An unusual case of vitamin D deficiency and Wernicke-Korsakoff syndrome
ea0021p87
Phaeochromocytoma/paraganglionoma patients in a joint endocrine genetic clinic setting
ea0021p88
Severe primary hyperparathyroidism (PHPT) and osteomalacia in pregnancy complicated by post parathyroidectomy hypocalcaemia related transient congestive cardiac failure (CCF): a case report
ea0021p89
Lithium-induced hypercalcemia and parathyroid dysfunction
ea0021p90
Failure of renin determined by immunoassay to suppress in a case of adrenocortical carcinoma secreting excess mineralocorticoid
ea0021p91
A case of spontaneously resolving occult ectopic ACTH-dependent Cushing's syndrome
ea0021p92
Reasons for treatment changes in hypogonadal men undergoing testosterone replacement
ea0021p93
An evaluation of the knowledge, motivation and weight-management service needs of obese young people
ea0021p94
Addison's disease: a new indication for continuous s.c. insulin infusion (CSII)?
ea0021p95
Primary antiphospholipid syndrome presenting as accelerated hypertension and adrenal haemorrhage associated with elevated urinary catecholamines
ea0021p96
The relationship between electrolyte disturbance and treatment with proton pump inhibitors
ea0021p97
Challenges in management of aggressive GH secreting tumors in adolescents
ea0021p98
Vitamin status after gastric bypass and lifestyle intervention: a comparative prospective study
ea0021p99
An unusual case of hypercalcaemia in an HIV positive man
ea0021p100
Utilising combined treatment modalities in non-islet cell tumour hypoglycaemia (NICTH)
ea0021p101
DIPNECH: precursor to pulmonary neuroendocrine tumors
ea0021p102
Ghrelin levels in patients with post hepatitis 'C' liver cirrhosis and hepatocellular carcinoma (HCC)
ea0021p103
A case of Verner-Morrison syndrome with solitary VIPoma and an incidental serous mucinous adenoma
ea0021p104
Risk of metabolic syndrome among Egyptian patients with schizophrenia
ea0021p105
Hypocalcaemia following thyroid surgery: impact on length of stay
ea0021p106
Audit of the management of metformin treated diabetic patients undergoing i.v. contrast procedures
ea0021p107
Hypoparathyroidism treated with Teriparatide and i.m. vitamin D
ea0021p108
Primary medical therapy of acromegaly
ea0021p109
Severe insulin resistance in hypothyroidism: a case report
ea0021p110
An unusual association of primary amenorrhoea and sleep dysfunction
ea0021p111
Somatostatin analogues as an alternative treatment for type 1 gastric endocrine tumour: case report
ea0021p112
Is a morning serum cortisol a useful screening test to rule out hypoadrenalism?
ea0021p113
The endocrine consequences of stem cell transplantation
ea0021p114
Endocrinopathy and low bone mineral density in thalassaemia
ea0021p115
Unemployment and return to work after the diagnosis of a chronic endocrine condition
ea0021p116
The use of the urine calcium/creatinine clearance ratio in patients with hypercalcaemia
ea0021p117
Salivary cortisol is a reliable marker to monitor hydrocortisone replacement
ea0021p118
Screening for glucose intolerance in young women with polycystic ovary syndrome: what is the optimum strategy?
ea0021p119
The role of adrenal vein sampling (AVS) in the diagnosis and management of primary hyperaldosteronism: an audit of 10 years experience at a tertiary referral centre
ea0021p120
Cytokines and growth factors
Peripheral blood mononuclear cells from active rheumatoid arthritis patients show a defective induction of adrenomedullin
ea0021p121
Impact of adiposity on dynamic changes of serum adipokines after OGTT
ea0021p122
Interaction of endothelin, aldosterone and bone morphogenetic proteins on mitotic actions of pulmonary arterial smooth muscle cells isolated from pulmonary arterial hypertension
ea0021p123
PTTG promotes mitogenic mechanisms in thyroid cells through autocrine pathways of interaction with TGF-[alpha], EGF and IGF1
ea0021p124
Does SOCS2 mediate inflammatory induced growth retardation?
ea0021p125
Differential effects of eicosapentaenoic acid (EPA) and palmitate on tumour necrosis factor (TNF-[alpha]) and insulin-like growth factor (IGF1) action in murine skeletal muscle cells
ea0021p126
Atrophy or hypertrophy: differential responses of C2 and C2C12 mouse skeletal myoblasts in the absence or presence of tumour necrosis factor-[alpha] (TNF-[alpha])
ea0021p127
Blood pressure, renal cytokines and biochemical parameters improve in morbidly obese patients after bariatric surgery
ea0021p128
Diabetes and metabolism
Profile of elderly patients with diabetes admitted into Obafemi Awolowo University Teaching Hospital
ea0021p129
Factitious hypoglycaemia in a patient without diabetes
ea0021p130
Gender and the metabolic syndrome in type 2 DM
ea0021p131
Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices
ea0021p132
Pancreatic polypeptide: a novel substrate for the endopeptidase neprilysin
ea0021p133
Bariatric surgery in renal transplant recipients
ea0021p134
Testosterone replacement therapy has no effect on ultrasound assessed carotid artery stiffness and intima-media thickness in men with insulin treated type 2 diabetes
ea0021p135
A novel role for neuropeptide Y in the regulation of energy homeostasis
ea0021p136
Salicylate induces insulin sensitivity by alleviating endoplasmic reticulum (ER) stress in cultured primary human adipocytes
ea0021p137
Herbal remedies as a cause of recurrent hypoglycaemia
ea0021p138
The effects of chloroquine on blood glucose and plasma insulin concentrations in male Sprague-Dawley rats
ea0021p139
The impact of thiazolidinediones on microalbuminuria in adults with type 2 diabetes mellitus: a systematic review
ea0021p140
Diabetic keto-acidosis in patients with Type 2 diabetes mellitus: a relatively common occurrence, the severity of which correlates with HbA1c
ea0021p141
Healthcare professionals frequently fail to recognise severe obesity
ea0021p142
Starvation ketoacidosis in pregnancy
ea0021p143
Protective effects of annexin A1 in experimental endotoxaemia are mediated by an FPR-dependent mechanism
ea0021p144
Toll-like receptor 2 (TLR2) as a biomarker for cardiovascular diseases in type 2 diabetes mellitus patients
ea0021p145
Regulation of the melanocortin receptor accessory protein (MRAP) in Y1 adrenal cells
ea0021p146
Annexin 1 affords cerebroprotection in sepsis
ea0021p147
The lipoprotein lipase HindIII polymorphism and susceptibility to hypertension
ea0021p148
Intravitreal bevacizumab injection for proliferative diabetic retinopathy
ea0021p149
Diabetic ketoacidosis: a 5-year retrospective analysis
ea0021p150
Effect of rimonabant and metformin on oxidative stress in obese patients with polycystic ovary syndrome (PCOS)
ea0021p151
At high dietary fat levels, dietary fish-oil may enhance metabolic efficiency but may favour a reduction in the deposition of adipose tissue
ea0021p152
A role for aquaglyceroporins in adipogenesis
ea0021p153
Infidelity of ectopic transcription using a pseudo splice site: lessons from HNF-1[beta] mutation causing familial juvenile hyperuricaemic nephropathy
ea0021p154
Patients with Turner syndrome have a high incidence of metabolic abnormalities
ea0021p155
Impact of extra cellular matrix changes on adipogenesis
ea0021p156
The hyperphagic effect of ghrelin is inhibited by diets high in fat in mice
ea0021p157
Nuf mice with an activating calcium sensing receptor mutation, Leu723Gln, have a metabolic acidosis and impaired urinary acidification
ea0021p158
Brain natriuretic peptide shows no response to acute hypobaric hypoxia in humans
ea0021p159
Total pancreatectomy and pancreatic islet autotransplantation in patient with intractable pain caused by chronic pancreatitis
ea0021p160
Weight and glycaemic outcomes following bariatric surgery in people with type 2 diabetes
ea0021p161
Effect of Ramadan fasting on glycaemic control in type 2 diabetic patients on oral hypoglacaemic agents
ea0021p162
An exploration of the predictive factors for the early pleiotropic responses to exenatide therapy in patients with type 2 diabetes mellitus
ea0021p163
Expression of store-operated Orai channels in normal and diabetic kidney
ea0021p164
Metabolic phenotype in brothers' of women with polycystic ovarian syndrome
ea0021p165
Nuf mice with an activating calcium-sensing receptor mutation, Leu723Gln, have impaired glucose tolerance and reduced insulin secretion
ea0021p166
Liraglutide prevents endothelial damage triggered by glucose oscillations
ea0021p167
Glucocorticoid and insulin regulation of lipid metabolism in human adipocytes
ea0021p168
MOPDII and Alstrom syndrome: two centrosomopathies featuring severe insulin resistance and impaired adipogenesis
ea0021p169
A novel syndrome of IGF1 and insulin supersensitivity
ea0021p170
Biomarkers of the hypothalamic-pituitary-adrenal (HPA) axis for analysis of in vivo 11[beta]-hydroxysteroid dehydrogenase 1 inhibition
ea0021p171
Aldosterone production by the mouse adrenal gland is compromised by a high fat diet and 11[beta]-hydroxysteroid dehydrogenase type 1 deficiency
ea0021p172
Transdermal delivery of insulin using amidated pectin hydrogel patches
ea0021p173
Low testosterone level is associated with significant increase in mortality in patients with type 2 diabetes
ea0021p174
The effects of plant derived oleanolic acid bioactive compound on glycogenic enzymes in streptozotocin-induced diabetic rats
ea0021p175
Testosterone replacement may be beneficial in hypogonadal men with cardiovascular disease
ea0021p176
Mice harbouring the familial juvenile hyperuricaemic nephropathy disease-causing uromodulin (Tamm-Horsfall glycoprotein) mutation Cys125Arg, have a urine concentrating defect, progressive renal failure, and altered uric acid handling
ea0021p177
Investigating the role of ventromedial hypothalamic glucose-sensing neurones in the response to hypoglycaemia
ea0021p178
Functional muscarinic acetylcholine receptors are expressed in white and brown adipose tissue
ea0021p179
Impact of glucocorticoids upon lipogenesis and [beta]-oxidation in skeletal muscle
ea0021p180
The influence of HIV status and antiretroviral (ARV) therapy on expression of genes related to mitochondrial metabolism in human adipose tissue (AT)
ea0021p181
Deficiency in 11[beta]-hydroxysteroid dehydrogenase type 1 reduces systemic inflammation and inflammatory cell infiltration in atherosclerotic lesions of ApoE-/- mice
ea0021p182
Short sleep duration is independently associated with obesity in with Type 2 diabetes
ea0021p183
Vitamin D status relates to premature aortic sclerosis in South Asians -- a novel risk factor for cardiovascular disease?
ea0021p184
Diet-induced obesity in C57Bl/6 mice is associated with sex-specific changes in glucocorticoid metabolism
ea0021p185
Circadian rhythmicity is altered in hepatic corticosterone-related genes from diet induced obese mice
ea0021p186
Down-regulation of adipose 11[beta]HSD1 mediates the insulin sensitising effects of salicylate in obesity
ea0021p187
Endocrine tumours and neoplasia
Ovarian Leydig cell tumour in a peri-menopausal woman with severe hyperandrogenism and virilisation
ea0021p188
Laparoscopic versus open adrenalectomy and adjuvant mitotane in adrenocortical carcinoma
ea0021p189
An unusual presentation of insulinoma with postabsorptive hypoglycaemia?
ea0021p190
A family with functional extraadrenal paragangliomas and positive SDHB gene mutation
ea0021p191
Medical management of an insulinoma - a safe long-term alternative to surgery?
ea0021p192
Two cases of meningitis as a complication of pituitary adenoma
ea0021p193
A case of phaeochromocytoma mimicking an acute ischemic limb: an unusual presentation
ea0021p194
Ectopic Cushings complicated by paraneoplastic cerebral vasculopathy requiring high-dose steroid therapy
ea0021p195
Cranioplasty for extensive skull deposit in the management of differentiated thyroid cancer
ea0021p196
Pseudophaeochromocytoma syndrome associated with Modafinil
ea0021p197
An unusual case of rapidly progressing pituitary lesion
ea0021p198
Cinacalcet treatment of resistant hypercalcaemia due to MEN1-associated primary hyperparathyroidism in pregnancy
ea0021p199
A case of Carcinoid syndrome without liver metastasis
ea0021p200
Choroidal malignant melanoma in a patient with Carney complex
ea0021p201
A rare case of steroid responsive non-islet cell tumour hypoglycemia (NICTH) secondary to metastatic haemangiopericytoma
ea0021p202
Adrenal venous sampling for catcholamines- a normal value study
ea0021p203
Temozolomide-induced regression of hepatic metastases in a pituitary corticotroph carcinoma with low O6-methylguanine-DNA methyltransferase expression
ea0021p204
Secretory glomus jugulare tumour treated with steriotactic radio surgery
ea0021p205
Case report: multiple endocrine neoplasia type 2a and hereditary haemorrhagic telangiectasia presenting consecutively in a single patient
ea0021p206
Parathyroidectomy has no impact on haemoglobin levels on patients with primary hyperparathyroidism
ea0021p207
Low incidence of hypocalcaemia after thyroidectomy in patients administered routinely oral calcium supplements
ea0021p208
Utilization of various imaging modalities in the localization of tumours in MEN-1 and insulinoma
ea0021p209
Functional characterisation of aryl hydrocarbon receptor interacting protein (AIP) promoter and silent mutations
ea0021p210
Investigating the role of HIF-1[alpha] in tumour growth and metastasis in an in vivo model of thyroid cancer
ea0021p211
Routine central compartment lymph node dissection for papillary thyroid cancer has minimal impact on early postoperative parameters
ea0021p212
Concordance between thyroglobulin antibody assays
ea0021p213
Mutations of the transcription factor, GATA3, in oestrogen receptor positive breast cancers
ea0021p214
Receptor-based scintigraphic imaging of insulinoma and glucagonoma in MEN-1
ea0021p215
Expression and regulation of oestrogen sulfotransferase (EST) in human ovarian surface epithelium (OSE) and epithelial ovarian cancer (EOC)
ea0021p216
Is the anti-proliferative effect of AIP (aryl hydrocarbon receptor interacting protein) via ZAC transcription factor?
ea0021p217
The role of PBF in NIS and MCT8 cellular trafficking
ea0021p218
MEN2B patients with a RET A883F mutation have less aggressive MTC than those with the common RET M918T mutation
ea0021p219
First report of SOX2 loss of function associated with a large hypothalamo-pituitary tumour; further insights into the role of SOX2 in pituitary development
ea0021p220
Pro-opiomelanocortin is a novel biomarker for small cell lung cancer
ea0021p221
Parafibromin, a tumour suppressor protein, interacts with transforming acidic-coiled coil protein 3 and kinesin family member 5B
ea0021p222
Open or laparoscopic surgery for phaeochromocytoma
ea0021p223
PBF is induced by ionising radiation and functionally inactivates p53 in thyroid cancer
ea0021p224
Mitotane treatment has profound effects on cortisol catabolism
ea0021p225
The microRNA let-7a is downregulated in pituitary tumours from a multiple endocrine neoplasia type-1 mouse model
ea0021p225.1
Growth and development
Klinefelter's syndrome often remains undiagnosed or diagnosed late
ea0021p226
Altered responses to GH and IGF1 in children born small for gestational age without post-natal catch up growth
ea0021p227
Delayed puberty in children with inflammatory bowel disease may be associated with gonadotrophin resistance
ea0021p228
Familial growth hormone deficiency - response to growth hormone therapy and analysis of the GH-1 and GHRH-R genes
ea0021p229
The impact of IBD on pubertal growth is most marked in boys with Crohn's disease
ea0021p230
Phenotypic presentation of P450 oxidoreductase deficiency during puberty
ea0021p231
Loss of the Golgi localised E3 ubiquitin ligase containing Cullin 7 in the growth disorder 3-M syndrome leads to reduced cell proliferation and reduced IGF1 mediated activation of Akt
ea0021p232
A novel dominant-negative Glial Cells Missing B (GCMB) mutation (Asn502His) is associated with autosomal dominant hypoparathyroidism and results in reduced transactivation activity
ea0021p233
Neuroendocrinology and behaviour
Sleep is frequently disordered in patients irradiated for brain tumours
ea0021p234
Intra-cerebral haemorrhage in a young woman with phaeochromocytoma
ea0021p235
The endocrine and behavioural effects of high fat feeding
ea0021p236
Profiling the metabolic clearance and enzymatic degradation of the gut hormone Peptide YY as a tool to design long-acting PYY3-36 analogues in treating obesity
ea0021p237
Characterising the role of 11[beta]-hydroxysteroid dehydrogenase type 1 (11[beta]-HSD1) in viral meningitis
ea0021p238
Alarin stimulates food intake and the hypothalamo-pituitary-gonadal axis in male rats
ea0021p239
Transgenic disruption of 5alpha-reductase 1 in mice results in a blunted stress response
ea0021p240
Pituitary
Stress hormone response in men at high altitude: effect of ethnicity
ea0021p241
Hypopituitarism secondary to pituitary apoplexy- is it due to high dose Aspirin?
ea0021p242
Not every pituitary apoplexy is caused by pituitary haemorrhage
ea0021p243
Management of non-functioning pituitary adenomas in a University Hospital: aretrospective analytical audit
ea0021p244
Lymphocytic hypophysitis or Sheehan's syndrome?
ea0021p245
Management of diabetes insipidus during pregnancy
ea0021p246
Thyrotropin-secreting pituitary tumour causing high output cardiac failure
ea0021p247
Is it pituitary adenoma or metastasis?: an unusual presentation of carcinoma prostate
ea0021p248
Sub-optimal testosterone replacement in acromegaly
ea0021p249
TSH-secreting pituitary adenoma: potential benefits of pre-operative octreotide
ea0021p250
An uncommon cause of hypopituitarism
ea0021p251
Herpes encephalitis causing hypopituitarism
ea0021p252
The effects of 3 year growth hormone replacement on the lipid profile of adults with growth hormone deficiency using a fixed graded initiation, followed by a titration phase method: 3-year retrospective analysis
ea0021p253
Adverse prognosis in breast cancer patients who develop pituitary metastases
ea0021p254
High incidence of survivors of childhood malignancy in an endocrine transition service
ea0021p255
Hypopituitarism following Russell's Viper bite: a case report
ea0021p256
Carcinomatous change in a craniopharyngioma: a case report
ea0021p257
Outcome of treatment for patients with acromegaly in a single referral centre
ea0021p258
An interesting case of intrasellar cavernous carotid aneurysm mimicking pituitary adenoma
ea0021p259
Solitary pituitary metastasis from carcinoma of the prostate: a case report
ea0021p260
Glucocorticoid replacement therapy and fibrinolysis in hypopituitarism
ea0021p261
Prolonged remission of acromegaly after cessation of somatostatin analogue treatment
ea0021p262
Spontaneous remission of Cushing's disease: apoplexy of a pituitary microadenoma?
ea0021p263
Both acetylcholine and choline stimulate externalisation of annexin 1 from S100-positive folliculo-stellate cells of the pituitary gland
ea0021p264
Gender differences in presentation and response to treatment for prolactin-secreting adenoma
ea0021p265
Cabergoline therapy is associated with successful abolition of abnormal cycles of excess steroid excretion in a case of pituitary dependent Cushing's disease
ea0021p266
Endocrine outcomes of pituitary surgery
ea0021p267
Recurrent meningitis secondary to an invasive TSHoma
ea0021p268
When should an MRI pituitary scan be performed in hypogonadal men with low or low normal LH?
ea0021p269
Hypothalamic resistance to signals of energy reserve, rather than excess appetite stimulation, may contribute to obesity in CP patients
ea0021p270
The effect of pituitary surgery on VEGF, MMP 2 and MMP 9 levels in acromegaly and non-functioning pituitary adenomas
ea0021p271
Obesity and cardiovascular risk factors in adult patients with acquired structural hypothalamic damage
ea0021p272
The R304X mutation of the Aryl hydrocarbon receptor interacting protein (AIP) gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect?
ea0021p273
Rathke's cleft cysts in need of regular follow-up in case of recurrence
ea0021p274
Recurrence rates in patients with non-functioning pituitary adenomas presenting with acute apoplexy: a long-term follow-up study
ea0021p275
Pituitary gonadotrophinoma and ovarian-hyperfunctioning: link or coincidence?
ea0021p276
Somatotroph adenoma subtype and responsiveness to somatostatin analogues in patients with acromegaly
ea0021p277
Remission rate in microprolactinomas treated with dopamine agonists
ea0021p278
Echocardiography in patients with hyperprolactinaemia treated with dopamine agonists: what happens in daily clinical practice and what are the findings?
ea0021p279
Treatment experience in 11 patients with gigantism
ea0021p280
The actions of long-term opioids for persistent pain on anterior pituitary hormones
ea0021p281
Cortisol but not GH responses are dependent on symptoms during the glucagon stimulation test
ea0021p282
Presentation, management and outcomes in acute pituitary apoplexy: a single centre experience from the United Kingdom
ea0021p283
Validity of the new pituitary apoplexy guideline group scoring system (PAGGS) in the management of pituitary apoplexy: a large retrospective review of 46 patients with classical pituitary apoplexy
ea0021p284
Electrocardiographic features in Cushing's disease: are there specific EKG changes associated with hypercortisolemia?
ea0021p285
Oral and transdermal oestrogen treatments have differing effects on GH sensitivity in hypopituitary women receiving GH replacement
ea0021p286
Patients with pituitary disease are at risk of under-replacement with levothyroxine
ea0021p287
Anti-allergic cromolyn drugs facilitate annexin 1 secretion from pituitary folliculo-stellate cells
ea0021p288
A fall in serum prolactin level after a 2-h rest predicts a normal MRI in patients using dopamine antagonist treatment
ea0021p289
Adult GH replacement and risk of tumour recurrence: 15 years experience from a large single centre
ea0021p290
Fish and chicks: C-type natriuretic peptide and the development of the pituitary gland in Gallus gallus and Danio rerio
ea0021p291
Circadian and pulsatile secretion of copeptin, an arginine vasopressin (AVP) marker, argues against a physiological role of AVP in cortisol release
ea0021p292
Long-term unsynchronised transcriptional cycles in individual living pituitary cells
ea0021p293
Can we ever stop imaging in surgically treated and radiotherapy naive patients with non-functioning pituitary adenoma?
ea0021p294
Effects on insulin action of dehydroepiandrosterone sulphate replacement in hypopituitary females
ea0021p295
Cabergoline suppression test: assessment tool for management of hyperprolactinemia
ea0021p296
Should we take macroprolactinoma patients off dopamine agonists at 3 or 5 years as they almost invariably recur?
ea0021p297
Onset of prolactin gene transcription in nascent pituitary lactotroph cells
ea0021p298
Immuno-modulatory role of prolactin in immune tissues driven by the alternative promoter
ea0021p299
Genetic screening for variability in regulatory regions of SOX2 and implications for hypothalamo-pituitary development
ea0021p300
Adults with partial GH deficiency (GHD) show phenotypic dichotomy related to the timing of onset of the deficiency
ea0021p301
The effect of the familial pituitary adenoma gene AIP on apoptosis
ea0021p302
Oncogene-induced senescence occurs in human pituitary adenomas
ea0021p303
Pituitary tumours of mice deleted for a multiple endocrine neoplasia type 1 allele have alterations in apoptotic pathway components
ea0021p304
MicroRNAs, miR-15a and miR-16-1, are implicated in pituitary tumourigenesis via regulation of cyclin D1
ea0021p305
Reproduction
Direct control of ovarian functions by ghrelin
ea0021p306
Androsterone glucuronide does not differ between nonobese and obese Caucasian women with polycystic ovary syndrome despite a higher DHEAS in nonobese subjects
ea0021p307
In vivo validation of potential natural products' abortifacient property mediated through modulation of uterine protein and vascular endothelial growth factor-C expression in foetal-maternal interface in albino rats
ea0021p308
Alteration of uterine receptivity and modulation of uterine protein expression during periimplantation by natural product from Piper species leads to pregnancy disruption in albino rats
ea0021p309
Factors that influence the decision to perform a karyotype in suspected disorders of sex development: lessons from The Scottish Genital Anomaly Network Register
ea0021p310
A possible cardioprotective role for metformin in PCOS: a study of clot structure and fibrinolysis
ea0021p311
Clinical experience of Nebido: monitoring the efficacy and safety of testosterone undecanoate in men over 60 years of age
ea0021p312
A simple modification of a commercial RIA to enable the more accurate measurement of serum testosterone in women
ea0021p313
GLUT4 expression and translocation in immortalised mouse granulosa cells
ea0021p314
The role of thyroid hormone transporters MCT8 and MCT10 in the EVT-like cell line HTR8-SVneo
ea0021p315
The tyrosine phosphatase, SHP-1, acts on multiple tyrosine kinase receptors to negatively regulate human cytotrophoblast proliferation
ea0021p316
Localisation of adiponectin receptors in normal and polycystic ovaries
ea0021p317
Expression of adhesion molecules in preantral mouse follicles
ea0021p318
Establishment of an in vitro model to study oocyte regulation of gene expression in granulosa cells of preantral follicles
ea0021p319
Activation of testicular melanocortin 3 receptors (MC3-R) inhibits LH-stimulated testosterone production
ea0021p320
Study of serum visfatin in Egyptian women with polycystic ovary syndrome
ea0021p321
Interaction between fibroblast growth factor-8 and bone morphogenetic proteins in regulation of ovarian steroidogenesis by rat granulosa cells
ea0021p322
Kiss1 mRNA and kisspeptin immunoreactivity are differentially regulated in hypothalamus and visceral fat in a rat model of polycystic ovary syndrome (PCOS)
ea0021p323
Apparent under-reporting of polycystic ovary syndrome in primary care
ea0021p324
Pregnancy adversely affects ability to recall previously seen spatial locations
ea0021p325
Female mice expressing constitutively active FSH receptor present with a phenotype of premature follicle depletion, premature aging and teratomas
ea0021p326
Sexual dimorphism in experimental endotoxaemia
ea0021p327
Twice-weekly administration of kisspeptin leads to long-term stimulation of reproductive hormone release in infertile women with hypothalamic amenorrhoea
ea0021p328
Steroids
Metyrapone interference in serum cortisol immunoassay
ea0021p329
Cyclical epilepsy associated with testosterone replacement
ea0021p330
Group education improves patient confidence in managing steroid sick day rules
ea0021p331
Steroid analysis in patients receiving metyrapone therapy
ea0021p332
Reference range data on androsterone glucuronide in healthy male and female volunteers and clinical uses of the assay
ea0021p333
A rare cause of massive bilateral adrenal enlargement complicating management of congenital adrenal hyperplasia
ea0021p334
Diagnostically difficult Cushing's syndrome in a pharmacy student
ea0021p335
Post-traumatic hypoadrenalism case report
ea0021p336
Determination of tandem mass spectrometry specific reference ranges for testosterone, androstenedione and DHEAS
ea0021p337
A sensitive and specific tandem mass spectrometry assay for the measurement of salivary testosterone
ea0021p338
Analysis of cortisol by stable isotope dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS): pitfalls of rapid LC-MS/MS analysis of clinical samples
ea0021p339
Steroid replacement: an unusual alternative to oral therapy via 24-h s.c. infusion device
ea0021p340
Moderate liquorice consumption enhances salivary DHEA and testosterone levels in healthy volunteers
ea0021p341
Is a raised DHEAS significant when analysed as part of an androgen profile
ea0021p342
Application of a highly specific and sensitive ELISA for the estimation of cortisone in biological fluids
ea0021p343
Successful fecundity with addition of night-time dexamethasone to hydrocortisone in a patient with congenital adrenal hyperplasia (CAH) and testicular adrenal rest tumours (TART)
ea0021p344
Dexamethasone testing and visceral:subcutaneous fat ratios in patients with adrenal incidentalomas
ea0021p345
Salivary aldosterone is a useful marker of serum aldosterone in normotensive individuals
ea0021p346
Regulation of glucocorticoid receptor activity by cellular stress
ea0021p347
-344 C/T polymorphism of aldosterone synthase gene (CYP11B2) and cortisol synthesis in heart failure patients
ea0021p348
Urinary steroid metabolite profiling in 11[beta]-HSD1 and H6PDH transgenic mice
ea0021p349
Epitopes of pterin-dependent hydroxylases in autoimmune polyendocrine syndrome type 1
ea0021p350
Responses of putative adrenocortical stem/progenitor cells and transiently amplifying cells to ACTH
ea0021p351
Assessing adrenal status in patients before and after coronary artery bypass graft surgery
ea0021p352
Ongoing symptoms in treated Addison's disease significantly impair health-related quality of life
ea0021p353
Low testosterone and androgen receptor insensitivity results in decreased AMP-activated protein kinase activity (AMPK) in the liver in the testicular feminised (Tfm) mouse
ea0021p354
Salivary annexin 1 has a diurnal rhythm but does not share an awakening response with cortisol at 30 min
ea0021p355
Use of bioluminescence resonance energy transfer to reveal the structural dynamics of the ACTH receptor complex
ea0021p356
6-Phosphogluconate dehydrogenase: an NADPH-generating enzyme in the lumen of the endoplasmic reticulum
ea0021p357
Hepatic vein cannulation and stable isotope tracer infusion reveals that liver cortisol regeneration by 11[beta]-HSD1 is sustained in obese men with type 2 diabetes mellitus, providing a target for enzyme inhibition
ea0021p358
Variation in the aldosterone synthase gene may alter gene transcription via altered transcription factor binding
ea0021p359
Replicated association of regions at CYP11B1/B2 locus with hypertension in Caucasians
ea0021p360
Anti-inflammatory effects of SGRMs: are they dependent on DUSP1?
ea0021p361
MicroRNA expression profiling of non-tumorous adrenal tissue and modulation of 11[beta]-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes by miR-24
ea0021p362
Is increased 11[beta]-HSD1 expression a key factor underpinning intrinsic and extrinsic skin aging?
ea0021p363
Functional characterisation of 21-hydroxylase gene mutations is a valuable tool for genetic counselling: in vitro and in silico analysis of six novel CYP21A2 sequence variants
ea0021p364
Chronic glucocorticoid treatment causes de novo methylation of Tpit and causes continued reduction in POMC expression after glucocorticoid withdrawal
ea0021p365
Thyroid
Spectrum of thyroid disorders in Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife
ea0021p366
Expensive but unreliable: Wayne's index to the rescue!
ea0021p367
A case of severe hypothyroidism treated with supervised weekly thyroxine
ea0021p368
A difficult case of very aggressive thyroid eye disease
ea0021p369
A case of non-Graves thyroid eye disease
ea0021p370
The unrestricted use of baseline thyroid function tests in elderly and female patients is justified in the diagnosis of thyroid dysfunction
ea0021p371
Technetium pertechnetate scanning in the differential diagnosis of benign thyroid disease
ea0021p372
Audit on fine needle aspiration of thyroid
ea0021p373
The many faces of hyperthyroidism in primary care
ea0021p374
A case of spousal abuse secondary to thyrotoxicosis
ea0021p375
A 10-year retrospective analysis of variable-dose radioactive iodine therapy for hyperthyroidism
ea0021p376
An unusual presentation of hyperthyroidism
ea0021p377
Incidence and predictors of transient hypothyroidism or euthyroidism following radioactive iodine therapy for hyperthyroidism
ea0021p378
The safety and efficacy of iopanoic acid in the pre-surgical management of thyrotoxicosis
ea0021p379
Audit of TSH-receptor antibodies and 99m technetium pertechnetate scintigraphy in the diagnosis of thyrotoxicosis aetiology
ea0021p380
Do we warn patients about the risk of neutropenia associated with the use of anti-thyroid drugs?
ea0021p381
Severe thyrotoxicosis due to metastatic differentiated thyroid carcinoma
ea0021p382
Pancytopenia and nephrotic syndrome related to autoimmune hypothyroidism: a case report
ea0021p383
Radioactive-iodine therapy: a patient satisfaction survey
ea0021p384
Atypical presentation of Riedel's thyroiditis: multifocal nodular fibrosis and resolution with levothyroxine
ea0021p385
Interpreting adrenal status in thyrotoxicosis
ea0021p386
Bulbar myopathy as a rare presenting feature of severe thyrotoxicosis in an elderly man
ea0021p387
Radioactive iodine (RAI) therapy for benign thyroid disease: joint RAI clinic
ea0021p388
TSH receptor antibody assay: its use in a tertiary centre
ea0021p389
Thyrotoxicosis presenting as intussusception
ea0021p390
Practical value of 131I whole body scan in follow up of patients with differentiated thyroid cancer
ea0021p391
An audit of the management of all patients with thyroid cancer treated with 131I for remnant ablation or persistent disease at a tertiary referral hospital between 2003 and 2008
ea0021p392
Radioiodine for Graves' disease: what do patients really think?
ea0021p393
Treated Grave's disease? think again!
ea0021p394
An evidence based protocol for the early identification and management of hypocalcaemia following total thyroidectomy
ea0021p395
A case of thyroid hormone resistance in a family with three generations of thyroid disease
ea0021p396
The use of district-wide laboratory database to identify new patients with persistent hyperthyroidism
ea0021p397
Dilated cardiomyopathy and atrial fibrillation secondary to resistance to thyroid hormone
ea0021p398
Iopanoic acid: a bridge to surgery when all else fails in complicated hyperthyroidism
ea0021p399
Selective malabsorption of thyroid hormone or selective intake?
ea0021p400
Management and follow up of post-operative hypocalcemia after thyroidectomy: a pilot study
ea0021p401
Clinical management and outcomes of anti-TSH receptor antibody positive pregnancies
ea0021p402
123I uptake scanning after radioiodine treatment for thyrotoxicosis prevents delayed diagnosis of radioiodine induced hypothyroidism
ea0021p403
Sunitinib induced hypothyroidism: a retrospective analysis
ea0021p404
Screening and management of thyroid dysfunction in pregnancy
ea0021p405
Diagnostic and financial benefits of checking TSH receptor antibodies in patients with thyrotoxicosis
ea0021p406
Should the cytological finding of Thy 3 mandate surgical excision?
ea0021p407
Characteristics of patients requiring more than one dose of radioactive iodine to induce cure of hyperthyroidism
ea0021p408
Screening of six novel candidate genes for association with Graves' disease
ea0021p409
The physiological role of thyroid hormone in the hypothalamic ventromedial nucleus
ea0021p410